Published: Guidance, quality standards and advice
Showing 461 to 470 of 1550
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Self‑harm | QS34 | ||
| Brolucizumab for treating diabetic macular oedema | TA820 | ||
| Faecal microbiota transplant for recurrent Clostridioides difficile infection | HTG638 | ||
| Contrast-enhanced spectral mammography for breast cancer | MIB304 | ||
| Differential target multiplexed spinal cord stimulation for chronic lower back and leg pain | MIB305 | ||
| iFuse for treating chronic sacroiliac joint pain | HTG488 | ||
| Avalglucosidase alfa for treating Pompe disease | TA821 | ||
| Transcutaneous electrical neuromuscular stimulation for urinary incontinence | HTG636 | ||
| Superficial venous arterialisation for chronic limb threatening ischaemia | HTG637 | ||
| Focal resurfacing implants to treat articular cartilage damage in the knee | HTG635 |